ABCB1 and cancer: This process takes advantage of aberrant expression of cell surface proteins, allows increased internalisation by cancer cells, and has been shown to bypass drug efflux by P-glycoprotein, also known as multidrug resistance protein 1 (P-gp or MDR1), thereby overcoming chemoresistance and improving the therapeutic response [24,25,26].